2006 Fiscal Year Final Research Report Summary
Effects of acrylamide on signal transduction
| Project/Area Number |
17590527
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Hygiene
|
|---|
| Research Institution | University of Occupational and Environmental Health |
|---|
Principal Investigator |
IGISU Hideki University of Occupational and Environmental Health, Inst Ind Ecol Sci, Professor, 産業生態科学研究所, 教授 (60108686)
|
|---|
| Project Period (FY) |
2005 – 2006
|
| Keywords | acrylamide / SH-SY5Y / MAPK / ERK / p53 / apoptosis / UO126 / neurotoxicity |
|---|
| Research Abstract |
Using human neuroblastoma SH-SY5Y cells, effects of acrylamide on p53 protein and intracellular signal transducting pathways were examined. Acrylamide increased p53, phosphorylated p53, and p53-associated protein murine double minute 2 (MDM2). The phosphorylation of p53 was specific for the Ser15 site. Among mitogen-activated protein kinases (MAPKs), acrylamide caused phosphorylation of extracellular signal-regulated protein kinase (ERK) and p38 but not c-Jun NH2-terminal kinase. Nevertheless, blocking p38 pathway by LL-Z1640-2 did not suppress the phosphorylation of p53 at Ser15. In contrast, a specific inhibitor of ERK kinase (U0126 or PD98059) could abolish the accumulation as well as the phosphorylation of p53. Elevation of MDM2 was also abolished by U0126. An inhibitor of phosphatidylinositol 3-kinase-related kinase (PIKK) pathway (wortmannin) suppressed the increase of p53 and its phosphorylation. Hence, acrylamide increases p53 protein and its phosphorylation at Ser15 through ER
… More
K and/or PIKK pathways. On the other hand, U0126 and PD98059 suppressed to some extent the cytotoxicity of acrylamide evaluated by trypan blue exclusion and lactate dehydrogenase (LDH) leakage, whereas neither LL-Z1640-2 nor wortmannin was effective in suppressing the toxicity. Thus, ERK pathway seems to play a role both in causing the phosphorylation of p53 and in the cytotoxicity of acrylamide in SH-SY5Y cells.
Acrylamide (1-5 mM) dose-dependently decreased cell viability in SH-SY5Y cells. The caspase-3 activity and cell population in sub-G1 phase were elevated and peaked on exposure to 3 mM acrylamide, while both were less so at higher dose (4 and 5 mM). Z-VAD-fmk, a pan-caspase inhibitor, lowered the apparent cytotoxicity of acrylamide. U0126 suppressed the elevation of caspase-3 activities as well as that of sub-G1 population. Thus, although mechanisms other than caspase-dependent apoptosis may be involved, apoptotic process seems to take place in the genesis of toxicity of acrylamide in SH-SY5Y cells through ERK pathway and activation of caspase-3. Less
|
